Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03302234
Brief Title: Study of Pembrolizumab Given With Ipilimumab or Placebo in Participants With Untreated Metastatic Non-small Cell Lung Cancer (MK-3475-598/KEYNOTE-598)

First Submitted : September 26, 2017
First Submitted that Met QC Criteria : October 4, 2017
First Posted : October 5, 2017

Last Update Submitted that Met QC Criteria : December 28, 2020
Last Update Posted : December 29, 2020